Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Marie-Antoinette Lester"'
Autor:
Christophe Desprez, Achille Kouatchet, Tony Marchand, Jean Baptiste Mear, Jean Marc Tadié, Pierre Peterlin, Patrice Chevalier, Emmanuel Canet, Marie-Anne Couturier, Gaelle Guillerm, Laetitia Bodenes, Emmanuel Gyan, Alban Villate, Stephan Ehrmann, Anne Lebreton, Marie-Antoinette Lester, Clémentine Fronteau, Gaelle Larhantec, Virginie André, Jérémie Riou, Mathilde Hunault-Berger, Aline Schmidt-Tanguy, Corentin Orvain
Publikováno v:
Annals of Hematology. 102:1383-1393
Autor:
Anissa Adoum, Pho Viet Anh Diane Le, Sophie Faisant, Pauline Legendre, Marie-Antoinette Lester, Pierre-Nicolas Boivin
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy. 7
Objectives Amiodarone hydrochloride is a class III antiarrhythmic drug indicated for the treatment of ventricular and supraventricular tachycardias. Oral amiodarone is only available in a tablet dosage form, which is not suitable for pediatric use. T
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 5, Iss 1, Pp 1565-73 (2020)
Objectives In patients suffering from chronic liver disease, the hepatic metabolism of drugs is perturbed and the metabolic capacity is difficult to assess. Midazolam could be used as a phenotypical probe to predict the metabolic capacity of CYP3A to
Autor:
Pierre-Nicolas Boivin, Pauline Rault, Marie-Antoinette Lester, Romain Bellay, Anne-Claire Bonnaure
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 3, Iss 2, Pp 49-57 (2018)
Background Prednisone is a corticosteroid used in several inflammatory diseases and cancers. In France, no available prednisone drinkable formulation exists. Instead, an oral syrup of prednisone with ethanol, sodium benzoate and simple syrup is produ
Autor:
Caroline Gay, Richard Delarue, Noel Milpied, Lucie Oberic, Bertrand Coiffier, Sami Boussetta, Corinne Haioun, Hervé Tilly, Gilles Salles, Thierry Lamy, Marie-Antoinette Lester, Roch Houot
Publikováno v:
Blood
Blood, 2017, 129 (20), pp.2811-2813. ⟨10.1182/blood-2017-02-766147⟩
Blood, American Society of Hematology, 2017, 129, pp.2811-2813. 〈10.1182/blood-2017-02-766147〉
Blood, American Society of Hematology, 2017, 129 (20), pp.2811-2813. ⟨10.1182/blood-2017-02-766147⟩
Blood, 2017, 129 (20), pp.2811-2813. ⟨10.1182/blood-2017-02-766147⟩
Blood, American Society of Hematology, 2017, 129, pp.2811-2813. 〈10.1182/blood-2017-02-766147〉
Blood, American Society of Hematology, 2017, 129 (20), pp.2811-2813. ⟨10.1182/blood-2017-02-766147⟩
International audience; In 2012, the American Society of Clinical Oncology (ASCO) published guidelines regarding the dosing of chemotherapy for obese patients with cancer.1 In these patients, empiric dose reductions are often performed, usually by ca
Autor:
Isabelle Cardiet, Emmanuelle Leray, Véronique Deburghgraeve, Marie-Antoinette Lester, Emmanuelle Le Page, Gilles Edan
Publikováno v:
Journal of Neurology
Journal of Neurology, Springer Verlag, 2015, 262 (4), pp.1024-1034. ⟨10.1007/s00415-015-7653-3⟩
Journal of Neurology, 2015, 262 (4), pp.1024-1034. ⟨10.1007/s00415-015-7653-3⟩
Journal of Neurology, Springer Verlag, 2015, 262 (4), pp.1024-1034. ⟨10.1007/s00415-015-7653-3⟩
Journal of Neurology, 2015, 262 (4), pp.1024-1034. ⟨10.1007/s00415-015-7653-3⟩
International audience; Our study aimed to describe safety and neurological impact of alemtuzumab as last-line rescue therapy in aggressive multiple sclerosis (MS) patients, previously treated by Mitoxantrone (MITOX). Between June 2004 and October 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a4ac14717888fba9b48b69aee25e3df
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01132657
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01132657
Autor:
Brendan Le Dare, Fabienne Aubin, Sylvaine Lefeuvre, Marie-Antoinette Lester, Pauline Roge, Pierre-Nicolas Boivin, Romain Bellay, Bertrand Bruneau, Camille Barbazan, Eric Joncourc, Anne Rucheton, Elisabeth Polard
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 51:82
Introduction L’hydrate de chloral est un sedatif utilise chez l’enfant en dose unique dans le cadre de la premedication des actes d’imagerie. En France, ce medicament est disponible dans le cadre d’Autorisation temporaire d’utilisation (ATU